Navigation Links
CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
Date:3/26/2008

More Than 5,000 Lung Cancer Patients Treated With CyberKnife System to Date

SUNNYVALE, Calif., March 26 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that approximately 90 percent of CyberKnife centers worldwide are now treating lung cancer with the CyberKnife(R) Robotic Radiosurgery System*. The number of lung cancer patients is growing significantly as well, with more than 5,000 individuals receiving CyberKnife treatments to date.

Lung cancer deaths are predicted to increase dramatically, according to a recent report from the World Health Organization (WHO). Lung cancer is expected to become more prominent in the underdeveloped world as a result of an anticipated rise in the use of tobacco products, which is the primary cause of approximately 80 percent of all lung cancer. The WHO "Report On The Global Tobacco Epidemic" projects that lung cancer incidence will increase from 18 million cases in the 20th century to 180 million cases in the 21st century worldwide. The majority of lung cancer cases are expected to be concentrated in 10 countries: China (30 percent of all cases), India (10 percent), Indonesia, Russia, the United States, Japan, Brazil, Bangladesh, Germany and Turkey.

"CyberKnife represents an important advance in the treatment of lung cancer. The CyberKnife System's unparalleled accuracy allows me to offer an effective, non-invasive treatment option for patients with early-stage lung cancer who are not good candidates for surgery," Richard Whyte, M.D., professor of cardiothoracic surgery at Stanford University Medical Center.

In many cases, patients with lung cancer also suffer from other medical conditions that could preclu
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
2. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
8. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
9. FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania
10. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
11. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... CARLOS, Calif., Dec. 2 SleepQuest...lued accreditation from the Joint Commission on th...HO) by demonstrating compliance,with national sta... "In becoming accredited, SleepQuest was evaluate...t Commission,s home care service survey team,",sa...
(Date:12/2/2008)...UMBIA, Md., Dec. 2 Marte...ced that it intends to release the results of its ..., 2008, at approximately 4:00 p.m. Eastern Time (E... will conduct a conference call to discuss these r... listen to the call live via webcast by visiting M...
(Date:12/2/2008)...Track to File NDA with FDA in Early to Mid-2009 ,...FirstCall/ -- Strativa Pharmaceuticals, the propri...anies, Inc. (NYSE: PRX ) today announced that it...ccessful completion of all pivotal bioequivalence .... The ondansetron thin film product is being devel...
(Date:12/2/2008)... DIEGO, Dec. 2 BrainCells Inc. (BC...tform technology to identify and,develop compound...reatment of,central nervous system (CNS) diseases...mpson to its board of directors. Thompson is a vet...ar tenure at Eli Lilly and Co. where he,focused o...
Breaking Biology Technology:SleepQuest Achieves Coveted Accreditation 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 2BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 3
...W. Turek and Guy C. Le Breton, Department of Pharm...ege of Medicine, Chicago, IL 60612.,Address corr... Department,of Pharmacology M/C 868, University ...l: jturek1@icarus.uic.edu , , ...mboxane A 2 (TXA 2 ) receptor, in addition to its...
.... Crispin,* Ru Chen,* Michael B. Kimmey,** Teresa ...s of Pathology and , **Medicine, Divisio...eattle, , Washington. , , ...is the fourth leading cause of cancer death in the...he time of diagnosis, 9699% of , patients...
...ller and Theresa Redila-Flores , Bio-Rad... , Introduction , Denat...f several methods , that can be used to s..., point mutations. In DGGE, the denaturin... of uniform temperature and a linear denaturant ...
... Introduction , The macular region of t...r , vision and most of the high, ..., known as the macula , lutea, or yellow ...f two closely-related compounds, lutein and zeaxan... dihydroxy-a-carotenes which differ in the positi...
Other Biology Technology:Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 2Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 3Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 4Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A 5Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE 2Detection of Mutant K-ras in a Kindred With Hereditary Pancreatic Cancer by DGGE 3DGGE Analysis Using the DCode System, Rev B 2DGGE Analysis Using the DCode System, Rev B 3Purification of the Components of Human Macular Carotenoid-Binding Complex, , Rev A 2Purification of the Components of Human Macular Carotenoid-Binding Complex, , Rev A 3
(Date:12/1/2008)...mber 2008 - The International Atomic Energy Agency... plant breeding technique that could bolster effor...hunger trap. , IAEA scientists use radiation to ...o harsh climate conditions such as drought or floo...nsect pests. Called mutation induction, the techni...
(Date:12/1/2008).... Scientists around the world may benefit from a ...that will help them to home in on the parts of pro... Sidow, PhD, associate professor of pathology and ...edicine, recently launched the novel bioinformatic...termining the role different proteins play in a wi...
(Date:12/1/2008)...la. The University of Florida, keeper of the worl... national records collection for another toothy ma... long rostrum or "saw" that makes it a popular cur...ome a historical and cultural icon that is rapidly...gist and curator of both the International Shark A...
(Date:12/1/2008)...if. For their landmark research leading to the de...farmers in flood-prone areas worldwide, Julia Bai... Davis and David Mackill of the International Ri...onored by the U.S. Department of Agriculture (USDA...Discovery Award. , The three scientists are, or ...
Breaking Biology News(10 mins):Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2UC Riverside rice geneticist receives high honor from US Department of Agriculture 2UC Riverside rice geneticist receives high honor from US Department of Agriculture 3Lifespring Health Sponsors the 30th Annual Napa Valley Marathon in an Effort to Promote Health and Fitness in the Northern California Community 12776 1AUDIO from Medialink and Transitions 3A Understanding the Dangers of UV Rays 12772 1HIV Drug in Microbicide Gel Safe for Daily Use 12771 1HIV Drug in Microbicide Gel Safe for Daily Use 12771 2Health Groups Launch Ad Campaign Supporting 70 Cent Increase in Kentucky Cigarette Tax 12768 1Health Groups Launch Ad Campaign Supporting 70 Cent Increase in Kentucky Cigarette Tax 12768 2
...archers have developed a "biobullet" that could he...S. waterways for nearly two decades clogging water...pecies and causing billions of dollars in industri...xins that dissolve within a zebra mussel,s digesti...liminating one of the world,s "most important econ...
...vings from sawmills can be used to produce an orga...containers. Moreover, this substrate has the advan...than other, imported ones such as peat or coconut ... the Public University of Navarre who, jointly wit...veloped this substrate material. The product has a...
...t The University of Manchester have created a new ...ronment for culturing cells in 3D, as published in...e gel is the first pH neutral material made from c...o provide an environment in which cells can be cul... the gel mimics the properties of cell scaffolds w...
... of human DNA have different structures that are t...ern Medical Center researchers have found in a stu...e study ?published in the Feb. 3 issue of the jour...ich are capped by segments called telomeres. Each ... they become too short, the aging cell can no long...
Other Biology News:'Biobullets' fight harmful mussels 2New organic substrate 2Manchester scientists create new bio-gel for 3D cell culture 2DNA end caps may lead to cancer treatments, UT Southwestern researchers report 2
Adjustable tilt angle 0 to 20 Adjustable speed of 3-25 RPM Load capacity: 2.7 kg (6 lbs.) Ambient temperature range 4C to 65C Low voltage power is supplied by wall mount transformer
Collected from sexually mature rats.
Request Info
Zymoclean Gel DNA Recovery Kit from Zymo Research
Biology Products: